Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 3,778 shares at $28.11 ($106K) on 2021-11-08, disclosed to the SEC on 2021-11-10.
Open-market sale of $106k TARS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.11 | 1,889 | $53K | 50.0% |
| 2 | $28.11 | 1,889 | $53K | 50.0% |
| Total | $28.11 avg | 3,778 | $106K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |